Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prostate Cancer Monitoring Using [18F]DCFPyL
NCT03585114Phase 2Active, not recruiting
- Sponsor
- Columbia University
- Start
- Dec 2018
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by Columbia University. Primary endpoint: Prevalence of changes in PyL PET imaging correlating with radiographic Progression-Free Survival (rPFS) at 6 weeks. Started Dec 2018; status: active, not recruiting.
Beyond the preview
Go deeper on NCT03585114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03585114.